, Tracking Stock Market Picks
Enter Symbol:
Rating: IRIX
Buy $11.50

Iridex Corporation (NASDAQ: IRIX) rated to Buy with price target $11.50 by Singular Research

Tuesday,  Jan 26, 2016  2:25 PM ET by Dave Ficere

Singular Research rated Iridex
Corporation (NASDAQ: IRIX) to Buy with price target $11.50.

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.

Singular Research

Latest Iridex Corporation recommendations:
Maxim Group rated Iridex Corporation (NASDAQ: IRIX) to Buy

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy